No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
H.C. Wainwright Maintains Collplant(CLGN.US) With Buy Rating, Maintains Target Price $11
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript Summary
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target
CollPlant Biotechnologies Analyst Ratings
Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025